JESSICA HINSON: Open Payments
NPI 1417229220 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,360 in 132 payments from 19 companies in 2025. Trend: 2023 $1,712 · 2024 $1,896 · 2025 $2,360
Food & beverage: $2,360
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $284 |
| ABBVIE INC. | 28 | $263 |
| GlaxoSmithKline, LLC. | 13 | $213 |
| Lilly USA, LLC | 19 | $209 |
| AstraZeneca Pharmaceuticals LP | 4 | $209 |
| PFIZER INC. | 13 | $207 |
| Abbott Laboratories | 4 | $180 |
| Amgen Inc. | 14 | $166 |
| Inspire Medical Systems, Inc. | 2 | $160 |
| Corcept Therapeutics | 5 | $138 |
Products named: MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, FREESTYLE LIBRE 3, NURTEC ODT, INSPIRE, Ozempic, OTEZLA.
Industry payments across OK — which companies pay providers there.
